49 related articles for article (PubMed ID: 17959394)
21. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
22. Detection of an elevated HER2 expression in MCF-7 breast cancer cells overexpressing estrogen receptor beta1.
Lattrich C; Juhasz-Boess I; Ortmann O; Treeck O
Oncol Rep; 2008 Mar; 19(3):811-7. PubMed ID: 18288420
[TBL] [Abstract][Full Text] [Related]
23. Differential characteristics of two new tumorigenic cell lines of human breast carcinoma origin.
Möbus VJ; Moll R; Gerharz CD; Kieback DG; Merk O; Runnebaum IB; Linner S; Dreher L; Grill HJ; Kreienberg R
Int J Cancer; 1998 Jul; 77(3):415-23. PubMed ID: 9663605
[TBL] [Abstract][Full Text] [Related]
24. Establishment and characterisation of new cell lines from human breast tumours initially established as tumour xenografts in NMRI nude mice.
Hambly RJ; Double JA; Thompson MJ; Bibby MC
Breast Cancer Res Treat; 1997 May; 43(3):247-58. PubMed ID: 9150904
[TBL] [Abstract][Full Text] [Related]
25. [Picture of the month. Ductal carcinoma of the breast].
Bang N; Vejborg IM; Nielsen MB
Ugeskr Laeger; 2000 Oct; 162(43):5787. PubMed ID: 11082681
[No Abstract] [Full Text] [Related]
26. Short-term primary culture of epithelial cells derived from human breast tumours.
Speirs V; Green AR; Walton DS; Kerin MJ; Fox JN; Carleton PJ; Desai SB; Atkin SL
Br J Cancer; 1998 Dec; 78(11):1421-9. PubMed ID: 9836473
[TBL] [Abstract][Full Text] [Related]
27. Well-differentiated neurotensin-producing neuroendocrine carcinoma of the breast. Report of a case.
La Rosa S; Usellini L; Riva C; Capella C
Histopathology; 2007 Dec; 51(6):846-7. PubMed ID: 17894802
[No Abstract] [Full Text] [Related]
28. The ninth ENBDC Weggis meeting: growth and in-depth characterisation of normal and neoplastic breast cells.
Wiese KE; Amante RJ; Vivanco MD; Bentires-Alj M; Iggo RD
Breast Cancer Res; 2017 Aug; 19(1):96. PubMed ID: 28830566
[TBL] [Abstract][Full Text] [Related]
29. Establishment and characterization of a receptor-negative, hormone-nonresponsive breast cancer cell line from an Iraqi patient.
Al-Shammari AM; Alshami MA; Umran MA; Almukhtar AA; Yaseen NY; Raad K; Hussien AA
Breast Cancer (Dove Med Press); 2015; 7():223-30. PubMed ID: 26300657
[TBL] [Abstract][Full Text] [Related]
30. DNMT3A and DNMT3B in Breast Tumorigenesis and Potential Therapy.
Man X; Li Q; Wang B; Zhang H; Zhang S; Li Z
Front Cell Dev Biol; 2022; 10():916725. PubMed ID: 35620052
[TBL] [Abstract][Full Text] [Related]
31. Silencing long non-coding RNA HOTAIR exerts anti-oncogenic effect on human acute myeloid leukemia via demethylation of HOXA5 by inhibiting Dnmt3b.
Wang SL; Huang Y; Su R; Yu YY
Cancer Cell Int; 2019; 19():114. PubMed ID: 31168296
[TBL] [Abstract][Full Text] [Related]
32. Establishment and characterization of three stable Basal/HER2-positive breast cancer cell lines derived from Chinese breast carcinoma with identical missense mutations in the DNA-binding domain of TP53.
Zhou F; Zhang Y; Xu X; Luo J; Yang F; Wang L; Xie S; Sun J; Yang X
Cancer Cell Int; 2018; 18():118. PubMed ID: 30140169
[TBL] [Abstract][Full Text] [Related]
33. Establishment and characterization of two primary breast cancer cell lines from young Indian breast cancer patients: mutation analysis.
Pandrangi SL; Raju Bagadi SA; Sinha NK; Kumar M; Dada R; Lakhanpal M; Soni A; Malvia S; Simon S; Chintamani C; Mohil RS; Bhatnagar D; Saxena S
Cancer Cell Int; 2014 Feb; 14(1):14. PubMed ID: 24502646
[TBL] [Abstract][Full Text] [Related]
34. Establishment and characterisation of two novel breast cancer cell lines.
Raju Bagadi SA; Kaur J; Ralhan R
Cell Biol Int; 2008 Jan; 32(1):55-65. PubMed ID: 17959394
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic reprogramming of breast cancer cells by valproic acid occurs regardless of estrogen receptor status.
Travaglini L; Vian L; Billi M; Grignani F; Nervi C
Int J Biochem Cell Biol; 2009 Jan; 41(1):225-34. PubMed ID: 18789398
[TBL] [Abstract][Full Text] [Related]
36. Eliminating epigenetic barriers induces transient hormone-regulated gene expression in estrogen receptor negative breast cancer cells.
Fleury L; Gerus M; Lavigne AC; Richard-Foy H; Bystricky K
Oncogene; 2008 Jul; 27(29):4075-85. PubMed ID: 18317449
[TBL] [Abstract][Full Text] [Related]
37. Triple-negative breast carcinoma in women from Vietnam and the United States: characterization of differential marker expression by tissue microarray.
Williams DJ; Cohen C; To TV; Page AJ; Lawson D; Sussman ZM; Nassar A
Hum Pathol; 2009 Aug; 40(8):1176-81. PubMed ID: 19368951
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of promoter hypermethylation of RASSF1A, RARbeta2, BRCA1 and HOXA5 in breast cancers of Indian patients.
Bagadi SA; Prasad CP; Kaur J; Srivastava A; Prashad R; Gupta SD; Ralhan R
Life Sci; 2008 Jun; 82(25-26):1288-92. PubMed ID: 18538349
[TBL] [Abstract][Full Text] [Related]
39. Breast cancer cell lines: friend or foe?
Burdall SE; Hanby AM; Lansdown MR; Speirs V
Breast Cancer Res; 2003; 5(2):89-95. PubMed ID: 12631387
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
